| Literature DB >> 25926778 |
Arantxa Alfaro1, Ángela Bernabeu2, Carlos Agulló2, Jaime Parra3, Eduardo Fernández4.
Abstract
Sensory substitution devices (SSDs) are providing new ways for improving or replacing sensory abilities that have been lost due to disease or injury, and at the same time offer unprecedented opportunities to address how the nervous system could lead to an augmentation of its capacities. In this work we have evaluated a color-blind subject using a new visual-to-auditory SSD device called "Eyeborg", that allows colors to be perceived as sounds. We used a combination of neuroimaging techniques including Functional Magnetic Resonance Imaging (fMRI), Diffusion Tensor Imaging (DTI) and proton Magnetic Resonance Spectroscopy ((1)H-MRS) to study potential brain plasticity in this subject. Our results suggest that after 8 years of continuous use of this device there could be significant adaptive and compensatory changes within the brain. In particular, we found changes in functional neural patterns, structural connectivity and cortical topography at the visual and auditive cortex of the Eyeborg user in comparison with a control population. Although at the moment we cannot claim that the continuous use of the Eyeborg is the only reason for these findings, our results may shed further light on potential brain changes associated with the use of other SSDs. This could help to better understand how the brain adapts to several pathologies and uncover adaptive resources such as cross-modal representations. We expect that the precise understanding of these changes will have clear implications for rehabilitative training, device development and for more efficient programs for people with disabilities.Entities:
Keywords: blindness; diffusion tensor imaging (DTI); functional magnetic resonance imaging (fMRI); magnetic resonance spectroscopy; neuroplasticity; sensory substitution device (SSD); visual cortex
Year: 2015 PMID: 25926778 PMCID: PMC4396351 DOI: 10.3389/fnsys.2015.00056
Source DB: PubMed Journal: Front Syst Neurosci ISSN: 1662-5137
Figure 1Visual stimulus and Functional Magnetic Resonance Imaging (fMRI) activation in the Eyeborg user and the control group. (A) Protocol of the Farnsworth-Munsell test. Within each scan series, the stimulus alternated between blocks of chromatic or achromatic discrimination trials and fixation. (B) Areas showing a significant response to chromatic stimulation in the Eyeborg user. (C) Areas showing a significant response to chromatic stimulation in two representative controls (single subjects). (D) Statistical parametric maps of the Eyeborg user are shown in standard anatomical space. (E) Statistical parametric maps of the whole control population in standard anatomical space.
Figure 2Analysis of the paradigm involving the presentation of simultaneously visual and auditory stimulation. (A) Data corresponding to the Eyeborg user (single subject analysis) showing a strong effect on temporal and occipital cortex. (B) Averaged activation of the control group in response to the same paradigm of stimulation.
Talairach coordinates and Z-scores of the maximally activated voxels associated with the presentation of simultaneously visual and auditory stimulation.
| Left | Hemisphere | Right | Hemisphere | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Brodman Area | Brodman Area | |||||||||
| −9.59 | −97.6 | 18.39 | 19.4 | 18 | 12 | −94 | 22 | 25 | 19 | |
| −63.59 | −11.2 | 3.99 | 15.62 | 22 | 33.6 | −79.6 | −21.2 | 18.8 | 18 | |
| −52.79 | −0.4 | −10.4 | 11.11 | 38 | 69.6 | −14.8 | 0.39 | 22.58 | 21 | |
| −34.79 | −36.4 | 18.39 | 10.09 | 13 | 58.8 | 13.99 | −6.8 | 15.65 | 38 | |
| −34.79 | 57.2 | −6.8 | 5.71 | 10 | 66 | −18.4 | 18.4 | 14.69 | 42 | |
| −27.6 | 57.2 | −3.2 | 5.53 | 10 | 48 | −36.4 | 25.6 | 8.8 | 13 | |
| 30 | 50 | −14 | 7.55 | 11 | ||||||
| 22.8 | 60.79 | −6.8 | 4.74 | 10 | ||||||
| 48 | 6.79 | 43.6 | 6.92 | 6 | ||||||
| 48 | 3.2 | 36.4 | 5.54 | 6 | ||||||
| −38.39 | −35.59 | −6.8 | 31.76 | 47 | 44.4 | −32.8 | 3.9 | 181 | 41 | |
| −45.6 | −35.6 | 14.79 | 17.99 | 46 | 26.4 | −79.6 | −10.4 | 169.13 | 18 | |
| −23.99 | 17.6 | 57.9 | 29.35 | 6 | 44.4 | 3.2 | 25.6 | 29.5 | 9 | |
| −38.4 | 3.2 | 54.4 | 23.45 | 6 | 37.2 | 6.79 | 25.6 | 20.74 | 9 | |
| −16.8 | 39.2 | 50.8 | 19.04 | 8 | 44.4 | −4 | 29.2 | 7.96 | 6 | |
| −34.79 | 13 | 29 | 24.2 | 9 | 40.8 | 35.6 | −14 | 27 | 11 | |
| −31.2 | −0.4 | 18.4 | 16.93 | 13 | 44.4 | 42.79 | −3.2 | 22.3 | 10 | |
| −42 | 6 | 22 | 20.04 | 9 | 66 | −40 | −14 | 12.42 | 21 | |
| −49.2 | −54 | 43.6 | 9.37 | 40 | 48 | −29.2 | 50.8 | 8.98 | 40 | |
| −34.8 | −54.4 | 54.4 | 3.23 | 7 | 55.2 | −22 | 36.4 | 5.47 | 2 | |
| −49.2 | −4 | 36.4 | 8.85 | 6 | 48 | −25 | 36 | 5.04 | 2 | |
| −49.2 | −11.2 | 47.2 | 6.21 | 4 | 33.6 | 3.2 | −17.6 | 5.62 | 38 | |
| −42 | −7.6 | 43.6 | 5.78 | 6 | 40.8 | 28.4 | 22 | 7.78 | 46 | |
| −49.2 | 28.4 | 32.8 | 6.25 | 9 | ||||||
| −49.2 | 21.2 | 36.4 | 6.08 | 9 | ||||||
| −52.79 | 13.99 | 32.79 | 3.5 | 9 |
Specification of active clusters at .
Diffusion Tensor Imaging results for white selected white matter tracts in the Eyeborg user and controls.
| FA value | ADC value (10−3MM2/S) | |||
|---|---|---|---|---|
| Eyeborg user | 0.57 ± 0.02* | 0.92 ± 0.03 | ||
| Controls | 0.52 ± 0.03 | 0.88 ± 0.02 | ||
| Eyeborg user | 0.53 ± 0.01 | 0.85 ± 0.02 | ||
| Controls | 0.49 ± 0.03 | 0.84 ± 0.04 | ||
| Eyeborg user | 0.51 ± 0.01 | 0.86 ± 0.02 | ||
| Controls | 0.48 ± 0.02 | 0.82 ± 0.04 | ||
| Eyeborg user | 0.51 ± 0.06 | 0.82 ± 0.02 | ||
| Controls | 0.45 ± 0.08 | 0.85 ± 0.09 | ||
| Eyeborg user | 0.50 ± 0.07 | 0.83 ± 0.01 | ||
| Controls | 0.48 ± 0.01 | 0.89 ± 0.02 |
FA = fractional anisotropy value; ADC = apparent diffusion coefficient; *.
Figure 3Tractography results. (A) Callosal fiber tracks in the Eyeborg user. (B) Callosal fiber tracks in a representative control subject (matched in age and sex). (C) Left inferior fronto-occipital fasciculus (IFOF), which connects the ventral occipital lobe and the orbitofrontal cortex, in the Eyeborg user. (D) Enlargement of the IFOF displayed in panel (C). The arrow points the region with increased myelin density related to the temporal lobe.
.
| Metabolite ratios | ||||
|---|---|---|---|---|
| Voxel Location | NAA/Cr | Glx/Cr | Cho/Cr | mIno/Cr |
| Eyeborg user | 1.53 | 1.74 | 0.46 | 0.42 |
| Controls | 1.45 ± 0.12 | 1.33 ± 0.31 | 0.52 ± 0.06 | 0.55 ± 0.09 |
| Eyeborg user | 1.63 | 1.27 | 0.56 | 0.57 |
| Controls | 1.41 ± 0.12 | 1.05 ± 0.30 | 0.44 ± 0.01 | 0.58 ± 0.12 |
| Eyeborg user | 1.48 | 0.93 | 0.43 | 0.8 |
| Controls | 1.44 ± 0.10 | 1.07 ± 0.17 | 0.64 ± 0.18 | 0.62 ± 0.11 |
(NAA), N-acetylaspartate and other N-acetyl-containing compounds. (Glx), Glutamate and Glutamine. (Cr), Creatine. (Cho), Choline. (mIno), Myo-inositol. Data obtained at .